These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28979536)

  • 1. Citrate versus non-citrate anticoagulation in continuous renal replacement therapy: Results following a change in local critical care protocol.
    Chowdhury SR; Lawton T; Akram A; Collin R; Beck J
    J Intensive Care Soc; 2017 Feb; 18(1):47-51. PubMed ID: 28979536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
    Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
    Sık G; Demirbuga A; Annayev A; Citak A
    Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
    Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
    Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial.
    Meersch M; Küllmar M; Wempe C; Kindgen-Milles D; Kluge S; Slowinski T; Marx G; Gerss J; Zarbock A;
    BMJ Open; 2019 Jan; 9(1):e024411. PubMed ID: 30670518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of continuous renal replacement therapy with regional citrate anticoagulation on a surgical and trauma intensive care unit: impact on clinical and economic aspects-an observational study.
    Hafner S; Stahl W; Fels T; Träger K; Georgieff M; Wepler M
    J Intensive Care; 2015; 3(1):35. PubMed ID: 26229685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Method to Improve Continuous Renal Replacement Therapy Circuit Survival Time in Critically Ill Coronavirus Disease 2019 Patients With Acute Kidney Injury.
    Volbeda M; Londema M; van Meurs M; Stegeman CA; Gansevoort RT; Berger SP; van der Voort PHJ; Franssen CFM
    Crit Care Explor; 2020 Oct; 2(10):e0258. PubMed ID: 33134948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous venovenous renal replacement therapy in critically ill patients: A work load analysis.
    Houllé-Veyssière M; Courtin A; Zeroual N; Gaudard P; Colson PH
    Intensive Crit Care Nurs; 2016 Oct; 36():35-41. PubMed ID: 27283118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C; Mao Z; Kang H; Hu J; Zhou F
    Crit Care; 2016 May; 20(1):144. PubMed ID: 27176622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation following a change in practice.
    Borg R; Ugboma D; Walker DM; Partridge R
    J Intensive Care Soc; 2017 Aug; 18(3):184-192. PubMed ID: 29118829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost.
    Wen M; Küchle C; Steubl D; Satanovskji R; Heemann U; Suttmann Y; Angermann S; Kemmner S; Rehbehn L; Huber M; Hauser C; Schmaderer C; Reichelt AL; Haller B; Renders L
    BMC Nephrol; 2018 Apr; 19(1):79. PubMed ID: 29614970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.
    Brain MJ; Roodenburg OS; Adams N; McCracken P; Hockings L; Musgrave S; Butt W; Scheinkestel C
    Crit Care Resusc; 2014 Jun; 16(2):131-7. PubMed ID: 24888284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.